49
views
0
recommends
+1 Recommend
0 collections
    1
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated psychiatric disorders in childhood. Typically, children with ADHD find it difficult to pay attention, they are hyperactive and impulsive.Methylphenidate is the drug most often prescribed to treat children and adolescents with ADHD but, despite its widespread use, this is the first comprehensive systematic review of its benefits and harms.

          Related collections

          Most cited references686

          • Record: found
          • Abstract: not found
          • Book: not found

          Diagnostic and Statistical Manual of Mental Disorders

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

            Systematic reviews should build on a protocol that describes the rationale, hypothesis, and planned methods of the review; few reviews report whether a protocol exists. Detailed, well-described protocols can facilitate the understanding and appraisal of the review methods, as well as the detection of modifications to methods and selective reporting in completed reviews. We describe the development of a reporting guideline, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015). PRISMA-P consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review. Funders and those commissioning reviews might consider mandating the use of the checklist to facilitate the submission of relevant protocol information in funding applications. Similarly, peer reviewers and editors can use the guidance to gauge the completeness and transparency of a systematic review protocol submitted for publication in a journal or other medium.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

              David Moher and colleagues introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses
                Bookmark

                Author and article information

                Journal
                Cochrane Database of Systematic Reviews
                Wiley
                14651858
                November 25 2015
                Affiliations
                [1 ]Region Zealand; Child and Adolescent Psychiatric Department; Birkevaenget 3 Roskilde Denmark 4300
                [2 ]Region Zealand Psychiatry; Psychiatric Research Unit; Slagelse Denmark
                [3 ]University of Southern Denmark; Department of Psychology, Faculty of Health Science; Campusvej 55 Odense Denmark 5230
                [4 ]Barsebäcksvägen 39 Löddeköpinge Sweden 24630
                [5 ]Psychiatric Centre North Zealand; The Capital Region of Denmark Denmark
                [6 ]Herlev University Hospital; Pediatric Department; Capital Region Herlev Denmark
                [7 ]Federal University of Rio Grande do Sul; Department of Psychiatry; Rua Ramiro Barcelos, 2350-2201A Porto Alegre RS Brazil 90035-003
                [8 ]Western Sydney Local Health District - Mental Health; Cumberland Hospital Locked Bag 7118 Parramatta NSW Australia 2124
                [9 ]Department of Health; Directorate for Health Information and Research; 95 G'Mangia Hill G'Mangia Malta PTA 1313
                [10 ]Whittington Health; Islington Child and Adolescent Mental Health Service; 580 Holloway Road London London UK N7 6LB
                [11 ]Christian Medical College; Cochrane South Asia, Prof. BV Moses Center for Evidence-Informed Health Care and Health Policy; Carman Block II Floor CMC Campus, Bagayam Vellore Tamil Nadu India 632002
                [12 ]Psychiatric Department, Region Zealand; Child and Adolescent Psychiatric Clinic; Holbaek Denmark
                [13 ]Copenhagen University; Institute of Clinical Medicine, Faculty of Health and Medical Sciences; Copenhagen Denmark
                [14 ]Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100
                [15 ]Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Copenhagen Denmark
                Article
                10.1002/14651858.CD009885.pub2
                26599576
                45a56828-b9a8-451c-9a50-21c5d0ad21a1
                © 2015
                History

                Comments

                Comment on this article